Get started
Author

Adham Alhaji

Observed institution: Sidra Medical and Research Center
OpenAlex ID: A5110318889
Second-line treatment option for children aged 18 years and under with an acute severe asthma exacerbation: a systematic review and meta-analysis of randomised controlled trials
2025 · Ibtihal Siddiq Abdelgadir, Khalid Mudawi, et al. · Archives of Disease in Childhood · 4
Use of intravenous magnesium sulfate in addition to standard first-line treatment with inhaled/nebulised short-acting beta 2 agonist and systemic steroids in the management of acute asthma exacerbations in children: a systematic review and meta-analyses of randomised controlled trials
2025 · Ali Abdalla Hamud, Khalid Mudawi, et al. · Archives of Disease in Childhood · 4
Use of inhaled/nebulised ipratropium bromide in addition to standard first-line treatment with inhaled/nebulised short-acting beta 2-agonist and systemic steroid in the management of acute asthma exacerbations: a systematic review and meta-analysis of randomised controlled trials
2025 · Ali Abdalla Hamud, Khalid Mudawi, et al. · Archives of Disease in Childhood · 1
Use of intravenous short-acting beta-2 agonist in addition to standard first-line treatment versus placebo in children and adolescents with acute severe asthma exacerbation: a systematic review and meta-analysis
2025 · Ibtihal Siddiq Abdelgadir, Ali Hamud, et al. · Archives of Disease in Childhood · 1
Use of intravenous aminophylline in addition to the standard first-line treatment in children and adolescents with an acute asthma exacerbation: a systematic review and meta-analysis of randomised controlled trials
2025 · Khalid Mudawi, Ali Hamud, et al. · Archives of Disease in Childhood · 1
Not All Epstein–Barr Virus Infections End Well: Tuberculous Osteomyelitis Mimicking a Post-Viral Complication in a Toddler
2026 · Tallal Tntoush, Ramadan Salem, et al. · Zenodo (CERN European Organization for Nuclear Research)
Use of subcutaneous epinephrine in addition to standard first-line treatment with short-acting β2-agonist and systemic steroids in children and adolescents with an acute severe asthma exacerbation: a systematic review of randomised controlled trials
2026 · Khalid Mudawi, Ali Hamud, et al. · Archives of Disease in Childhood
Works count: 7
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type